标题
Nucleic Acid Drugs—Current Status, Issues, and Expectations for Exosomes
作者
关键词
-
出版物
Cancers
Volume 13, Issue 19, Pages 5002
出版商
MDPI AG
发表日期
2021-10-07
DOI
10.3390/cancers13195002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lumasiran: First Approval
- (2021) Lesley J. Scott et al. DRUGS
- Inclisiran: First Approval
- (2021) Yvette N. Lamb DRUGS
- Advancing drug discovery using the power of the human genome
- (2021) Karl Heilbron et al. JOURNAL OF PATHOLOGY
- Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
- (2021) John W Day et al. LANCET NEUROLOGY
- Durable vision improvement after a single treatment with antisense oligonucleotide sepofarsen: a case report
- (2021) Artur V. Cideciyan et al. NATURE MEDICINE
- Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs
- (2021) Shota Oyama et al. Cancers
- Golodirsen: First Approval
- (2020) Young-A Heo DRUGS
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
- (2020) David S. Hong et al. BRITISH JOURNAL OF CANCER
- MTL-CEBPA, a small activating RNA therapeutic up-regulating C/EBP-α, in patients with advanced liver cancer: a first-in-human, multi-centre, open-label, phase I trial
- (2020) Debashis Sarker et al. CLINICAL CANCER RESEARCH
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
- (2020) Paula R. Clemens et al. JAMA Neurology
- Viltolarsen: First Approval
- (2020) Sohita Dhillon DRUGS
- Combination molecular therapies for type 1 spinal muscular atrophy
- (2020) Yohei Harada et al. MUSCLE & NERVE
- Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria
- (2020) Prajakta Badri et al. CLINICAL PHARMACOKINETICS
- Exosome-based candidates move into the clinic
- (2020) Megan Cully NATURE REVIEWS DRUG DISCOVERY
- Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
- (2019) Eliane Sardh et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo RNA editing of point mutations via RNA-guided adenosine deaminases
- (2019) Dhruva Katrekar et al. NATURE METHODS
- Reassessment of Exosome Composition
- (2019) Dennis K. Jeppesen et al. CELL
- Benefits and limitations of genome-wide association studies
- (2019) Vivian Tam et al. NATURE REVIEWS GENETICS
- Onasemnogene Abeparvovec: First Global Approval
- (2019) Sheridan M. Hoy DRUGS
- Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis
- (2019) Xiaoping Zhang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- O.24Biodistribution of onasemnogene abeparvovec (AVXS-101) DNA, mRNA, and SMN protein in human tissue
- (2019) B. Kaspar et al. NEUROMUSCULAR DISORDERS
- Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
- (2019) Jinkuk Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent advances in siRNA delivery for cancer therapy using smart nanocarriers
- (2018) Penghui Zhang et al. DRUG DISCOVERY TODAY
- Treating cancer with microRNA replacement therapy: A literature review
- (2018) Nayer Hosseinahli et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer
- (2018) Vikash Reebye et al. ONCOGENE
- Paraspeckles: Where Long Noncoding RNA Meets Phase Separation
- (2018) Archa H. Fox et al. TRENDS IN BIOCHEMICAL SCIENCES
- Aptamer-based targeted therapy
- (2018) Guizhi Zhu et al. ADVANCED DRUG DELIVERY REVIEWS
- Inotersen: First Global Approval
- (2018) Susan J. Keam DRUGS
- Patisiran: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- Toxicological and Pharmacokinetic Properties of Chemically Modified siRNAs Targeting p53 RNA Following Intravenous Administration
- (2018) James D. Thompson et al. Nucleic Acid Therapeutics
- The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery
- (2018) Samuel A. Smith et al. BIOCONJUGATE CHEMISTRY
- A microRNA-29 mimic (remlarsen) represses extracellular matrix expression and fibroplasia in the skin
- (2018) Corrie L. Gallant-Behm et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- PCSK9 inhibitors: clinical evidence and implementation
- (2018) Marc S. Sabatine Nature Reviews Cardiology
- Integrated Assessment of the Clinical Performance of GalNAc3-Conjugated 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience
- (2018) Stanley T. Crooke et al. Nucleic Acid Therapeutics
- To Protect and to Preserve: Novel Preservation Strategies for Extracellular Vesicles
- (2018) Gina D. Kusuma et al. Frontiers in Pharmacology
- Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial
- (2017) Tomasz M Beer et al. LANCET ONCOLOGY
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer
- (2017) Jon Voutila et al. MOLECULAR THERAPY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Overcoming cellular barriers for RNA therapeutics
- (2017) Steven F Dowdy NATURE BIOTECHNOLOGY
- The functions and unique features of long intergenic non-coding RNA
- (2017) Julia D. Ransohoff et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNA editing with CRISPR-Cas13
- (2017) David B. T. Cox et al. SCIENCE
- Eteplirsen in the treatment of Duchenne muscular dystrophy
- (2017) Kenji Rowel Lim et al. Drug Design Development and Therapy
- Construction of a guide-RNA for site-directed RNA mutagenesis utilising intracellular A-to-I RNA editing
- (2017) Masatora Fukuda et al. Scientific Reports
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice
- (2016) Abderraouf Selmi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Oncogene Knockdown via Active Loading of Small RNAs into Extracellular Vesicles by Sonication
- (2016) Tek N. Lamichhane et al. Cellular and Molecular Bioengineering
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Combination therapeutics in complex diseases
- (2016) Bing He et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Intrathecal Injections in Children With Spinal Muscular Atrophy
- (2016) Manon Haché et al. JOURNAL OF CHILD NEUROLOGY
- Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
- (2016) Joana Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing
- (2016) Marie-Cécile Didiot et al. MOLECULAR THERAPY
- Harnessing human ADAR2 for RNA repair – Recoding a PINK1 mutation rescues mitophagy
- (2016) Jacqueline Wettengel et al. NUCLEIC ACIDS RESEARCH
- Engineering hybrid exosomes by membrane fusion with liposomes
- (2016) Yuko T. Sato et al. Scientific Reports
- Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics
- (2016) Peter Lönn et al. Scientific Reports
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
- (2015) Kazutaka Nishina et al. Nature Communications
- Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification
- (2015) Amy Chan et al. Molecular Therapy-Nucleic Acids
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice
- (2014) Thazha P. Prakash et al. NUCLEIC ACIDS RESEARCH
- Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
- (2014) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
- (2014) Fritz Eckstein Nucleic Acid Therapeutics
- Mipomersen Sodium: First Global Approval
- (2013) Philip Hair et al. DRUGS
- Mutant KRAS is a druggable target for pancreatic cancer
- (2013) E. Zorde Khvalevsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue-specific gene silencing monitored in circulating RNA
- (2013) A. Sehgal et al. RNA
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Design and Characterization of Novel Peptide-Coated Lipid Nanoparticles for Targeting Anti-HIV Drug to CD4 Expressing Cells
- (2012) Aaron N. Endsley et al. AAPS Journal
- An RNA-Deaminase Conjugate Selectively Repairs Point Mutations
- (2012) Thorsten Stafforst et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Clinical pharmacokinetics of second generation antisense oligonucleotides
- (2012) Rosie Z Yu et al. Expert Opinion on Drug Metabolism & Toxicology
- The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
- (2012) Steven M. Johnson et al. JOURNAL OF MOLECULAR BIOLOGY
- Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome
- (2012) Zhiyu Peng et al. NATURE BIOTECHNOLOGY
- Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
- (2012) Julien Zuber et al. Nature Reviews Nephrology
- Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
- (2011) R. J. Kelly et al. BLOOD
- An Overview of Sugar-Modified Oligonucleotides for Antisense Therapeutics
- (2011) Thazha P. Prakash CHEMISTRY & BIODIVERSITY
- Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
- (2011) M Diken et al. GENE THERAPY
- Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-mediated Delivery
- (2011) Bin Shi et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Endosomal escape pathways for delivery of biologicals
- (2010) Amir K. Varkouhi et al. JOURNAL OF CONTROLLED RELEASE
- Synthesis and Biophysical Evaluation of 2′,4′-Constrained 2′O-Methoxyethyl and 2′,4′-Constrained 2′O-Ethyl Nucleic Acid Analogues
- (2010) Punit P. Seth et al. JOURNAL OF ORGANIC CHEMISTRY
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
- (2010) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
- (2010) U. Bogdahn et al. NEURO-ONCOLOGY
- CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases
- (2009) Dennis M. Klinman et al. ADVANCED DRUG DELIVERY REVIEWS
- Antisense oligonucleotide pharmacokinetics and metabolism
- (2009) Richard S Geary Expert Opinion on Drug Metabolism & Toxicology
- siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury
- (2009) B. A. Molitoris et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
- (2008) M. Aleku et al. CANCER RESEARCH
- Current prospects for mRNA gene delivery
- (2008) Ayako Yamamoto et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer
- (2008) Kim N Chi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
- (2008) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone
- (2008) Yasushi Sato et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now